Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

First clinical experiences in treating oesophageal cancer with intensity-modulated proton therapy

Autor: Visser, S., Ribeiro, C. O., Dieters, M., Mul, V. E., Niezink, A., Knopf, A., Langendijk, J. A., Korevaar, E. W., Both, S., Muijs, C. T.

Publikováno v: Radiotherapy and Oncology, 170, S839-S841. ELSEVIER IRELAND LTD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7e0c65e77331ff12b0ecea4246701a2b
https://research.rug.nl/en/publications/e8c36050-dab3-4702-83d9-e638830730d5

A multivariable prediction model for severe toxicity after chemoradiation for esophageal cancer

Autor: Muijs, C., Oldehinkel, E., Pattipeiluhu, A., Niezink, A. G., Mul, V. E., Dieters, M., Etten, B., Schaaf, A., Langendijk, J. A.

Publikováno v: Radiotherapy and Oncology, 161, S379-S380. ELSEVIER IRELAND LTD
Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ff0dceb906c19d7f1ee52dbca7df78fd
https://research.rug.nl/en/publications/8de513da-632d-48e0-8f18-18e63b4e40c7

Commentaar op art. 338-344a Wetboek van Strafvordering

Autor: Dreissen, W.H.B., Boone, M.M., de Bruijn-Luckers, M.L.C.C., Ferdinandusse, W., Knobbout, G., Mul, V., Plaisier, M.J.A., van Strien, M.

Publikováno v: Sdu commentaar strafvordering: Deel 1: WvSv, 148-215
ISSUE=2019-2020;STARTPAGE=148;ENDPAGE=215;TITLE=Sdu commentaar strafvordering

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::15579d59084485812f3ebd4f98aaa427
https://research.ou.nl/en/publications/bc67afba-80f2-4197-a757-da4518e81d61

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): A multicenter observational study

Autor: Borggreve, A. S., Mook, S., Verheij, M., Mul, V. E.M., Bergman, J. J., Bartels-Rutten, A., Ter Beek, L. C., Beets-Tan, R. G.H., Bennink, R. J., Van Berge Henegouwen, M. I., Brosens, L. A.A., Defize, I. L., Van Dieren, J. M., Dijkstra, H., Van Hillegersberg, R., Hulshof, M. C., Van Laarhoven, H. W.M., Lam, M. G.E.H., Van Lier, A. L.H.M.W., Muijs, C. T., Nagengast, W. B., Nederveen, A. J., Noordzij, W., Plukker, J. T.M., Van Rossum, P. S.N., Ruurda, J. P., Van Sandick, J. W., Weusten, B. L.A.M., Voncken, F. E.M., Yakar, D., Meijer, G. J., Aleman, B. M.P., Borra, R. J.H., Van Etten, B., Gisbertz, S. S., Goense, L., Haj Mohammad, N., Hartemink, K. J., Kappert, P., Kats-Ugurlu, G., Kodach, L. L., Korteweg, T., Krishnadath, K. K., Langendijk, J. A., De Leng, W. W.J., Meijer, S. L., Potze, J. H., Stoker, J., Vegt, E., Verkooijen, H. M., Vollenbrock, S. E., Wessels, F.

Publikováno v: BMC Cancer
BMC Cancer, 18:1006. BMC
BMC Cancer, 18
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Cancer, 18(1). BioMed Central
BMC cancer, 18(1):1006. BioMed Central

Contains fulltext : 200332.pdf (Publisher’s version ) (Open Access) BACKGROUND: Nearly one third of patients undergoing neoadjuvant chemoradiotherapy (nCRT) for locally advanced esophageal cancer have a pathologic complete response (pCR) of the pri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a9677306e8ad3f992aec10350b2bd6
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055078905&origin=inward